Ulys, L.L.C. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872104. A total of 5 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Ulys, L.L.C. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$28,434,000
+3.3%
30,248,5050.0%99.96%
-0.0%
Q4 2014$27,526,000
-34.5%
30,248,505
+1.6%
99.98%
+0.0%
Q3 2014$41,993,000
-12.4%
29,782,6090.0%99.97%
+0.0%
Q2 2014$47,950,000
-6.9%
29,782,6090.0%99.96%
+0.0%
Q1 2014$51,524,000
-3.9%
29,782,6090.0%99.95%
+0.0%
Q4 2013$53,609,000
-24.4%
29,782,6090.0%99.92%
-0.0%
Q3 2013$70,883,000
+9.7%
29,782,6090.0%99.94%
+0.1%
Q2 2013$64,628,00029,782,60999.85%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Ulys, L.L.C. 29,782,609$41,993,00099.97%
Artal Group S.A. 253,372,135$357,255,00013.15%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 250,000$353,0001.25%
NEA Management Company, LLC 11,676,000$16,463,0000.84%
Round Table Services, LLC 151,280$213,0000.18%
Rhenman & Partners Asset Management AB 294,805$416,0000.12%
WILLIAM HARRIS INVESTORS INC 204,342$288,0000.09%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 2,592,900$3,656,0000.04%
Orbitronix, LP 50,000$71,0000.04%
UBS ASSET MANAGEMENT AMERICAS LLC 23,479,178$33,106,0000.03%
View complete list of LEXICON PHARMACEUTICALS INC shareholders